Trial Profile
FLOW Trial: Fluoxetine to Open the Critical Period Time Window to Improve Motor Recovery After Stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2022
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Paresis; Stroke complications
- Focus Therapeutic Use
- Acronyms FLOW
- 01 Nov 2022 Status changed from active, no longer recruiting to completed.
- 18 May 2022 Planned End Date changed from 30 Sep 2021 to 30 Sep 2022.
- 18 May 2022 Planned primary completion date changed from 30 Sep 2021 to 30 Sep 2022.